In an analysis of 147 studies, the performance of AFP in the diagnosis of HCC at a cut-off threshold of 20 ng/mL was found to be 60% and 84% for sensitivity and specificity, respectively. This evidence concerns the gene AFP and hepatocellular carcinoma.